Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease : = Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
BACKGROUND Studies have demonstrated a potential role for fecal biomarkers such as fecal calprotectin(FC) and fecal lactoferrin(FL) in monitoring inflammatory bowel diseases(IBD)-Crohn's disease(CD) and ulcerative colitis(UC).However,their correlation to endoscopic scores,disease severity and affected intestinal surface has not been extensively investigated.AIM To correlate FL,and for comparison white blood cell(WBC) and C-reactive protein(CRP),with endoscopic scores,disease extent and location in CD and UC.METHODS Retrospective analysis in 188 patients who had FL,CRP and WBC determined within 30 d of endoscopy.Disease location,disease extent(number of intestinal segments involved),disease severity(determined by endoscopic scores),timing of FL testing in relation to colonoscopy,as well as the use of effective fast acting medications(steroids and biologics) between colonoscopy and FL measurement,were recorded.RESULTS In 131 CD and 57 UC patients,both CRP and FL-but not WBC-distinguished disease severity(inactive,mild,moderate,severe).In patients receiving fastacting(steroids or biologics) treatment in between FL and colonoscopy,FL showed a higher correlation to endoscopic scores when tested before vs after the procedure(r = 0.596,P < 0.001,vs r = 0.285,P = 0.15 for the Simple Endoscopic Score for CD;and r = 0.402,P = 0.01 vs r = 0.054 P = 0.84 for Disease Activity Index).Finally,FL was significantly correlated with the diseased mucosal surface(colon-ileocolon > small bowel) and the number of inflamed colon segments.CONCLUSION FL and CRP separated disease severity categories with FL showing lower discriminating P-values.FL showed a close correlation with the involved mucosal surface and with disease extent and was more closely correlated to endoscopy when determined before the procedure – this indicating that inflammatory activity changes associated with therapy might be rapidly reflected by FL levels.FL can accurately and timely characterize intestinal inflammation in IBD..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019-12-31 2019 |
|---|---|
| Erschienen: |
2019-12-31 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2019 |
|---|---|
| Enthalten in: |
World Journal of Gastrointestinal Pathophysiology = 世界胃肠病理生理学杂志(电子版)(英文版) - (2019), 05 vom: 31. Dez., Seite 54-63 Original Letters: Enthalten in (DE-627)CAJ472975323 (DE-627)CAJ472975323 |
| Reihe: |
China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health |
|---|
| Sprache: |
Chinesisch |
|---|
| Weiterer Titel: |
Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease |
|---|
| Beteiligte Personen: |
Marrieth G Rubio [VerfasserIn] |
|---|
| Links: |
oversea.cnki.net [lizenzpflichtig] |
|---|
| Anmerkungen: |
Author info:Marrieth G Rubio;Kofi Amo-Mensah;James M Gray;Vu Q Nguyen;Sam Nakat;Douglas Grider;Kim Love;James H Boone;Dario Sorrentino;IBD Center-Division of Gastroenterology,Virginia Tech Carilion School of Medicine;Department of Radiology,Virginia Tech Carilion School of Medicine;Department of Basic Science Education;Virginia Tech Carilion School of Medicine and Dominion Pathology Associates;K.R.Love Quantitative Consulting and Collaboration;Research and Development,TECHLAB Inc;Department of Clinical and Experimental Medical Sciences,University of Udine School of Medicine |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CAJ647436922 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CAJ647436922 | ||
| 003 | DE-627 | ||
| 005 | 20230318183025.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230104s2019 cc |||||o 00| ||chi c | ||
| 035 | |a (DE-627)CAJ647436922 | ||
| 035 | |a (SBB-XA)CAJ_WJGY201905001 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 044 | |c XB-CN | ||
| 084 | |a ASIEN |q DE-1a |2 fid | ||
| 084 | |a R574 |2 clc | ||
| 100 | 0 | |a Marrieth G Rubio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease |b = Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease |
| 246 | 3 | 1 | |a Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease |
| 264 | 1 | |c 2019-12-31 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a China Academic Journals (CAJ) |a E |a 医药卫生科技 = Medicine & Public Health | |
| 500 | |a Author info:Marrieth G Rubio;Kofi Amo-Mensah;James M Gray;Vu Q Nguyen;Sam Nakat;Douglas Grider;Kim Love;James H Boone;Dario Sorrentino;IBD Center-Division of Gastroenterology,Virginia Tech Carilion School of Medicine;Department of Radiology,Virginia Tech Carilion School of Medicine;Department of Basic Science Education;Virginia Tech Carilion School of Medicine and Dominion Pathology Associates;K.R.Love Quantitative Consulting and Collaboration;Research and Development,TECHLAB Inc;Department of Clinical and Experimental Medical Sciences,University of Udine School of Medicine | ||
| 520 | |a BACKGROUND Studies have demonstrated a potential role for fecal biomarkers such as fecal calprotectin(FC) and fecal lactoferrin(FL) in monitoring inflammatory bowel diseases(IBD)-Crohn's disease(CD) and ulcerative colitis(UC).However,their correlation to endoscopic scores,disease severity and affected intestinal surface has not been extensively investigated.AIM To correlate FL,and for comparison white blood cell(WBC) and C-reactive protein(CRP),with endoscopic scores,disease extent and location in CD and UC.METHODS Retrospective analysis in 188 patients who had FL,CRP and WBC determined within 30 d of endoscopy.Disease location,disease extent(number of intestinal segments involved),disease severity(determined by endoscopic scores),timing of FL testing in relation to colonoscopy,as well as the use of effective fast acting medications(steroids and biologics) between colonoscopy and FL measurement,were recorded.RESULTS In 131 CD and 57 UC patients,both CRP and FL-but not WBC-distinguished disease severity(inactive,mild,moderate,severe).In patients receiving fastacting(steroids or biologics) treatment in between FL and colonoscopy,FL showed a higher correlation to endoscopic scores when tested before vs after the procedure(r = 0.596,P < 0.001,vs r = 0.285,P = 0.15 for the Simple Endoscopic Score for CD;and r = 0.402,P = 0.01 vs r = 0.054 P = 0.84 for Disease Activity Index).Finally,FL was significantly correlated with the diseased mucosal surface(colon-ileocolon > small bowel) and the number of inflamed colon segments.CONCLUSION FL and CRP separated disease severity categories with FL showing lower discriminating P-values.FL showed a close correlation with the involved mucosal surface and with disease extent and was more closely correlated to endoscopy when determined before the procedure – this indicating that inflammatory activity changes associated with therapy might be rapidly reflected by FL levels.FL can accurately and timely characterize intestinal inflammation in IBD. | ||
| 610 | 2 | 4 | |a IBD Center-Division of Gastroenterology,Virginia Tech Carilion School of Medicine |
| 610 | 2 | 4 | |a Department of Radiology,Virginia Tech Carilion School of Medicine |
| 610 | 2 | 4 | |a Department of Basic Science Education |
| 610 | 2 | 4 | |a Virginia Tech Carilion School of Medicine and Dominion Pathology Associates |
| 610 | 2 | 4 | |a K.R.Love Quantitative Consulting and Collaboration |
| 610 | 2 | 4 | |a Research and Development,TECHLAB Inc |
| 610 | 2 | 4 | |a Department of Clinical and Experimental Medical Sciences,University of Udine School of Medicine |
| 650 | 4 | |a 消化系及腹部疾病 | |
| 650 | 4 | |a 内科学 | |
| 650 | 4 | |a 医药、卫生 | |
| 650 | 4 | |a Digestive System Disease | |
| 650 | 4 | |a 医药卫生科技 | |
| 650 | 4 | |a Medicine & Public Health | |
| 650 | 4 | |a Inflammatory bowel disease | |
| 650 | 4 | |a Crohn's disease | |
| 650 | 4 | |a Ulcerative colitis | |
| 650 | 4 | |a Fecal lactoferrin | |
| 650 | 4 | |a C-reactive protein | |
| 650 | 4 | |a White blood cell count | |
| 650 | 4 | |a Mucosal inflammation | |
| 700 | 0 | |a Kofi Amo-Mensah |4 oth | |
| 700 | 0 | |a James M Gray |4 oth | |
| 700 | 0 | |a Vu Q Nguyen |4 oth | |
| 700 | 0 | |a Sam Nakat |4 oth | |
| 700 | 0 | |a Douglas Grider |4 oth | |
| 700 | 0 | |a Kim Love |4 oth | |
| 700 | 0 | |a James H Boone |4 oth | |
| 700 | 0 | |a Dario Sorrentino |4 oth | |
| 773 | 0 | 8 | |6 880-01 |i Enthalten in |t World Journal of Gastrointestinal Pathophysiology = 世界胃肠病理生理学杂志(电子版)(英文版) |g (2019), 05 vom: 31. Dez., Seite 54-63 |w (DE-627)CAJ472975323 |7 nnns |
| 773 | 1 | 8 | |g year:2019 |g number:05 |g day:31 |g month:12 |g pages:54-63 |
| 856 | 4 | 0 | |u http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=WJGY201905001 |x Verlag |y CrossAsia Link |z Deutschlandweit zugänglich |
| 856 | 4 | 0 | |u https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=WJGY201905001 |x Verlag |z lizenzpflichtig |
| 880 | 0 | 8 | |6 773-01/Hans |i Enthalten in |w (DE-627)CAJ472975323 |7 nnns |
| 912 | |a ZDB-1-CAJ | ||
| 912 | |a GBV_NL_CAJ | ||
| 912 | |a FID-ASIEN | ||
| 912 | |a SSG-OLC-OA3.1 | ||
| 912 | |a SSG-OLC-CAJ | ||
| 936 | u | w | |j 2019 |e 05 |b 31 |c 12 |h 54-63 |
| 951 | |a AR | ||
| 952 | |j 2019 |e 05 |b 31 |c 12 |h 54-63 | ||
| 980 | |2 11 |1 01 |x 0001 |b 666941599 |c 00 |f 5:FIDXASIA |d --%%-- |e --%%-- |j --%%-- |y k |z 04-01-23 | ||
| 981 | |2 11 |1 01 |x 0001 |r http://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=WJGY201905001 | ||